Table 3:
Cost-Effectiveness in Urban and Rural Settings, First Three Years
| Cases per 3 person-years (95% CI) | Cases averted per 3 person-years (95% CI) | Cost per case averted (95% CI) | |
|---|---|---|---|
| Lilongwe Urban | |||
| No bed net | |||
| No vaccine | 2·24 (1·45 to 3·46) | NA | NA |
| Four-dose vaccine | 1·15 (0·75 to 1·78) | 1·09 (0·53 to 1·93) | $23·86 (13·48 to 48·95) |
| Bed net | |||
| No vaccine | 1·38 (1·11 to 1·71) | NA | NA |
| Four-dose vaccine | 0·71 (0·57 to 0·88) | 0·67 (0·36 to 1·02) | $38·91 (25·55 to 72·90) |
| Lilongwe Rural | |||
| No bed net | |||
| No vaccine | *5·31 (4·81 to 5·96) | NA | NA |
| Four-dose vaccine | 2·72 (2·01 to 3·74) | 2·59 (1·62 to 3·38) | $10·08 (7·71 to 16·13) |
| Bed net | |||
| No vaccine | 3·26 (2·15 to 4·91) | NA | NA |
| Four-dose vaccine | 1·67 (1·01 to 2·77) | 1·59 (0·87 to 2·57) | $16·43 (10·16 to 30·06) |
*
The confidence interval only takes into account uncertainty in the reduction of the rate of malaria cases from the first 18 months to the second 18 months, not uncertainty in the base rate in the first 18 months.